Cohesion and the aneuploid phenotype in Alzheimer's disease: A tale of genome instability

Neuroscience and Biobehavioral Reviews

Volumn 55, Issue , 2015, Pages 365-374

  Bajic, Vladan ^a   Spremo Potparevic, Biljana ^b   Zivkovic, Lada ^b   Isenovic, Esma R ^a   Arendt, Thomas ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Alzheimer's disease (AD); Aneuploidy; Cell cycle; Cohesion; Genomic mosaicism

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; COHESIN; CYCLIN B; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 11; PROTEIN MAD2; PROTEIN P53; SECURIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; NONHISTONE PROTEIN;

ALZHEIMER DISEASE; ANAPHASE; ANEUPLOIDY; CELL ADHESION; CELL CYCLE REGULATION; CELL MIGRATION; CENTROMERE; CHROMOSOMAL INSTABILITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOMIC INSTABILITY; HUMAN; MICROTUBULE ASSEMBLY; MOSAICISM; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; BRAIN; CELL CYCLE; FEMALE; GENETICS; MALE; METABOLISM; NERVE CELL; PHENOTYPE;

ALZHEIMER DISEASE; ANEUPLOIDY; BRAIN; CELL CYCLE; CELL CYCLE PROTEINS; CHROMOSOMAL PROTEINS, NON-HISTONE; FEMALE; GENOMIC INSTABILITY; HUMANS; MALE; NEURONS; PHENOTYPE;

EID: 84930622205     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.05.010     Document Type: Review

References (144)

1. Almeida A., Bolaños J.P., Moreno S. Cdh1/Hct1-APC is essential for the survival of postmitotic neurons. J. Neurosci. 2005, 25:8115-8121.
2. Arendt T., Rodel L., Gartner U., Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 1996, 7:3047-3049.
3. Arendt T. Dysregulation of neuronal differentiation and cell cycle control in Alzheimer's disease. J. Neural Transm. Suppl. 2002, 62:77-85.
4. Arendt T., Bruckner M.K., Mosch B., Losche A. Selective cell death of hyperploid neurons in Alzheimer's disease. Am. J. Pathol. 2010, 177:15-19.
5. Arendt T. Cell cycle activation and aneuploid neurons in Alzheimer's disease. Mol. Neurobiol. 2012, 46:125-135.
6. Aulia S., Tang B.L. Cdh1-APC/C, cyclin B-Cdc2, and Alzheimer's disease pathology. Biochem. Biophys. Res. Commun. 2006, 6:1-6.
7. Baker-Nigh A., Shahrooz V., Goetz Davis E., Weintraub S., Bigio H.E., William L.K., Changiz G. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease. Brain 2015, 1-16.
8. Bajic P.V., Spremo-Potparevic B., Zivkovic L., Djelic N., Smith M.A. Is the time dimension of the cell cycle re-entry in AD regulated by centromere cohesion dynamics?. Biosci. Hypotheses 2008, 1:156-161.
9. Bajić P.V., Spremo-Potparević B., Živković L., Bonda D.J., Siedlak S.L., Casadesus G., Lee H., Smith M.A. The X-chromosome instability phenotype in Alzheimer's disease. A clinical sign of accelerating aging?. Med. Hypotheses 2009, 73(6):917-920.
10. Bajic V., Zivkovic L., Spremo-Potparevic B., Siedlak S., Smith M.A. RAD 21 cohesion protein shows altered levels of expression in Swedish mutant phenotype of M17 neuroblastoma cells. Alzheimers Dement. 2010, 6(4 Suppl.):S257.
11. Bajic P.V., Su B., Lee H.G., Kudo W., Siedlak S.L., Zivkovic L., Spremo-Potparevic B., Djelic N., Milicevic Z., Singh A.K., Fahmy L.M., Wang X., Smith M.A., Zhu X. Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease. Cell. Mol. Biol. Lett. 2011, 16(3):359-372.
12. Bajic V., Mandusic V., Stefanova E., Bozovic A., Davidovic R., Zivkovic L., Cabarkapa A., Spremo-Potparevic B. Skewed X-chromosome inactivation in women affected by Alzheimer's disease. J. Alzheimers Dis. 2015, 43:1251-1259.
13. Barbato C., Ciotti M.T., Serafino A., Calissano P., Cogoni C. Dicer expression and localization in post-mitotic neurons. Brain Res. 2007, 1175:17-27.
14. Barbero J.L. Sister chromatid cohesion control and aneuploidy. Cytogenet. Genome Res. 2011, 133:h223-h233.
15. Barbero J.L. Genetic basis of cohesinopathies. Appl. Clin. Genet. 2013, 1:15-23.
16. Boeras D.I., Granic A., Padmanabhan J., Crespo N.C., Rojiani A.M., Potter H. Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy. Neurobiol. Aging 2008, 29:319-328.
17. Bonda D.J., Bajic V.P., Spremo-Potparevic B., Casadesus G., Zhu X., Smith M.A., Lee H.G. Review: cell cycle aberrations and neurodegeneration. Neuropathol. Appl. Neurobiol. 2010, 36:157-163.
18. Bucholtz N., Demuth I. DNA-repair in mild cognitive impairment and Alzheimer's disease. DNA Repair (Amst.) 2013, 12:811-816.
19. Bushman D.M., Chun J. The genomically mosaic brain: aneuploidy and more in neural diversity and disease. Semin. Cell. Dev. Biol. 2013, 24:357-369.
20. Bushman D.M., Kaeser G.E., Siddoway B., Westra J.W., Rivera R.R., Rehen S.K., Yung Y.C., Chun J. Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains. Elife 2015, 4.
21. Cai X., Evrony G.D., Lehmann H.S., Elhosary P.C., Mehta B.K., Poduri A., Walsh C.A. Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain. Cell Rep. 2014, 8(5):1280-1289.
22. Carrasquillo M.M., Zou F., Pankratz V.S., Wilcox S.L., Ma L., Walker L.P., Younkin S.G., Younkin C.S., Younkin L.H., Bisceglio G.D., Ertekin-Taner N., Crook J.E., Dickson D.W., Petersen R.C., Graff-Radford N.R., Younkin S.G. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat. Genet. 2009, 41:192-208.
23. Carrel L., Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434(7031):400-404.
24. Casadesus G., Atwood C.S., Zhu X., Hartzler A.W., Webber K.M., Perry G., Bowen R.L., Smith M.A. Evidence for the role of gonadotropin hormones in the development of Alzheimer disease. Cell. Mol. Life Sci. 2005, 62:293-298.
25. Casadesus G., Puig E.R., Webber K.M., Atwood C.S., Escuer M.C., Bowen R.L., Perry G., Smith M.A. Targeting gonadotropins: an alternative option for Alzheimer disease treatment. J. Biomed. Biotechnol. 2006, 1-8.
26. Chan R.C., Chan A., Jeon M., Wu T.F., Pasqualone D., Rougvie A.E., Meyer B.J. Chromosome cohesion is regulated by a clock gene paralogue TIM-1. Nature 2003, 423:1002-1009.
27. Chan Y.W., On K.F., Chan W.M., Wong W., Siu H.O., Hau P.M., Poon R.Y. The kinetics of p53 activation versus cyclin E accumulation underlies the relationship between the spindle-assembly checkpoint and the postmitotic checkpoint. J. Biol. Chem. 2008, 283:15716-15723.
28. Chen F., Kamradt M., Mulcahy M., Byun Y., Xu H., McKay M.J., Cryns V.L. Caspase proteolysis of the cohesin component RAD21 promotes apoptosis. J. Biol. Chem. 2002, 277:16775-16781.
29. Chiang T., Duncan F.E., Schindler K., Schultz R.M., Lampson M.A. Evidence that weakened centromere cohesion is a leading cause of age-related aneuploidy in oocytes. Curr. Biol. 2010, 20(17):1522-1528.
30. Cimini D., Degrassi F. Aneuploidy: a matter of bad connections. Trends Cell Biol. 2005, 8:442-451.
31. Copani A., Hoozemans J.J., Caraci F., Calafiore M., Van Haastert E.S., Veerhuis R., Rozemuller A.J., Aronica E., Sortino M.A., Nicoletti F. DNA polymerase-beta is expressed early in neurons of Alzheimer's disease brain and is loaded into DNA replication forks in neurons challenged with beta-amyloid. J. Neurosci. 2006, 26(43):10949-10957.
32. Díaz-Martínez L.A., Giménez-Abián J.F., Clarke D.J. Regulation of centromeric cohesion by sororin independently of the APC/C. Cell Cycle. 2007, 6:714-724.
33. Dierssen M., Herault Y., Estivill X. Aneuploidy: from a physiological mechanism of variance to Down syndrome. Physiol. Rev. 2009, 89:887-920.
34. Disteche C.M. Escapees on the X chromosome. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:14180-14192.
35. Dongli H., Marcus V., Vincent J., Lahti J.M. CDK11p58 is required for the maintenance of sister chromatid cohesion. J. Cell Sci. 2008, 120:2424-2434.
36. Dorsett D. Roles of the sister chromatid cohesion apparatus in gene expression, development, and human syndromes. Chromosoma 2007, 116:1-13.
37. Dorsett D., Merkenschlager M. Cohesin at active genes: a unifying theme for cohesin and gene expression from model organisms to humans. Curr. Opin. Cell Biol. 2013, 25:327-333.
38. Escudero T., Coll M.D., Fuster C., Egozcue J. Chromatid segregation analysis in native human lymphocyte anaphases using sequential fluorescence in situ hybridization. Cytotechnology 2002, 39:171-175.
39. Evrony G.D., Cai X., Lee E., Hills L.B., Elhosary P.C., Lehmann H.S., Parker J.J., Atabay K.D., Gilmore E.C., Poduri A., Park P.J., Walsh C.A. Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain. Cell 2012, 151(3):483-496.
40. Finkel T., Serrano M., Blasco M.A. The common biology of cancer and ageing. Nature 2007, 448:767-774.
41. Fitzgerald P.H., Archer S.A., Morris C.M. Evidence for the repeated primary non-disjunction of chromosome 21 as a result of premature centromere division (PCD). Hum. Genet. 1986, 72:58-62.
42. Ford J.H. Spindle microtubular dysfunction in mothers of Down syndrome children. Hum. Genet. 1984, 68:295-308.
43. François M., Leifert W., Hecker J., Faunt J., Martins R., Thomas P., Fenech M. Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease. Cytometry A 2014, 85:698-708.
44. Fukagawa T., Nogami M., Yoshikawa M. Dicer is essential for formation of the heterochromatin structure in vertebrate cells. Nat. Cell Biol. 2004, 6:784-791.
45. Geller L.N., Potter H. Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease. Neurobiol. Dis. 1999, 6:167-179.
46. Gieffers C., Peters B.H., Kramer E.R., Dotti C.G., Peters J.M. Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons. Proc. Natl. Acad. Sci. U.S.A. 1999, 96(20):11317-11322.
47. Granic A., Padmanabhan J., Norden M., Potter H. Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP. Mol. Biol. Cell 2010, 21:511-520.
48. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road on the road to therapeutics. Science 2002, 19(5580):353-356.
49. Hébert S.S., Papadopoulou A.S., Smith P., Galas M.C., Planel E., Silahtaroglu A.N., Sergeant N., Buée L., De Strooper B. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum. Mol. Genet. 2010, 19:3959-3969.
50. Hecht F., Hecht B.K., Berger C.S. Aneuploidy in recurrent spontaneous aborters: the tendency to parental nondisjunction. Clin. Genet. 1984, 26(1):43-45.
51. Herrup K., Arendt T. Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease. J. Alzheimers Dis. 2002, 4:243-247.
52. Herrup K. The involvement of cell cycle events in the pathogenesis of Alzheimer's disease. Alzheimers Res. Ther. 2010, 2:13.
53. Herrup K. The contributions of unscheduled neuronal cell cycle events to the death of neurons in Alzheimer's disease. Front. Biosci. (Elite Ed.) 2012, 4:2101-2109.
54. Heston L.L., Mastri A.R. The genetics of Alzheimer's disease: associations with hematologic malignancy and Down's syndrome. Arch. Gen. Psychiatry 1977, 34:976-981.
55. Homer H.A., McDougall A., Levasseur M., Yallop K., Murdoch A.P., Herbert M. Mad2 prevents aneuploidy and premature proteolysis of cyclin B and securin during meiosis I in mouse oocytes. Genes Dev. 2005, 19:202-207.
56. Hoque M.T., Ishikawa F. Cohesin defects lead to premature sister chromatid separation, kinetochore dysfunction, and spindle-assembly checkpoint activation. J. Biol. Chem. 2002, 277:42306-42314.
57. Iourov I.Y., Vorsanova S.G., Yurov Y.B. Chromosomal variation in mammalian neuronal cells: known facts and attractive hypotheses. Int. Rev. Cytol. 2006, 249:143-191.
58. Iourov I.Y., Vorsanova S.G., Yurov Y.B. Molecular cytogenetics and cytogenomics of brain diseases. Curr. Genomics 2008, 9:452-465.
59. Iourov I.Y., Vorsanova S.G., Liehr Y.B., Yurov T. Neurobiology of disease, aneuploidy in the normal, Alzheimer's disease and ataxia-telangiectasia brain: differential expression and pathological meaning. Neurobiol. Dis. 2009, 34:212-220.
60. Iourov I.Y., Vorsanova S.G., Yurov Y.B. Somatic genome variations in health and disease. Curr. Genomics 2010, 11:387-396.
61. Jallepali P.V., Walzenegger I.C., Bunz F., Langer S., Speicher M.R., Peters J.M., Kinzler K.W., Vogelstein B., Lengauer C. Securin is required for chromosomal stability in human cells. Cell 2001, 105:445-457.
62. Kienitz A., Vogel C., Morales I., Müller R., Bastians H. Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol. Oncogene 2005, 24:4301-4310.
63. Kim A.H., Puram S.V., Bilimoria P.M., Ikeuchi Y., Keough S., Wong M., Rowitch D., Bonni A. A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons. Cell 2009, 136:322-336.
64. Kingsbury M.A., Friedman B., McConnell M.J., Rehen S.K., Yang A.H., Kaushal D., Chun J. Aneuploid neurons are functionally active and integrated into brain circuitry. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:6143-6147.
65. Kingsbury M.A., Yung Y.C., Peterson S.E., Westra J.W., Chun J. Aneuploidy in the normal and diseased brain. Cell. Mol. Life Sci. 2006, 63:2626-2641.
66. Kormann-Bortolotto M.H., de Arruda Cardoso Smith M., Toniolo Neto J. Alzheimer's disease and ageing: a chromosomal approach. Gerontology 1993, 39:1-6.
67. Kumamoto T., Oshio S. Effect of fetal exposure ot bisphenol/A on brain mediated by X-chromosome inactivation. J. Toxicol. Sci. 2013, 38:485-494.
68. Lee H.G., Casadesus G., Zhu X., Castellani R.J., McShea A., Perry G., Petersen R.B., Bajic V., Smith M.A. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochem. Int. 2009, 54:84-88.
69. Leland S., Nagarajan P., Polyzos A., Thomas S., Samaan G., Donnell R., Marchetti F., Venkatachalam S. Heterozygosity for a Bub1 mutation causes female-specific germ cell aneuploidy in mice. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:12776-12781.
70. Matsuura S., Matsumoto Y., Morishima K., Izumi H., Matsumoto H., Ito E., Tsutsui K., Kobayashi J., Tauchi H., Kajiwara Y., Hama S., Kurisu K., Tahara H., Oshimura M., Komatsu K., Ikeuchi T., Kajii T. Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome. Am. J. Med. Genet. A 2006, 140:358-367.
71. McKay M.J., Troelstra C., van der Spek P., Kanaar R., Smit B., Hagemeijer A., Bootsma D., Hoeijmakers J.H. Sequence conservation of the rad 21 schizosaccharomyces pombe DNA double-strand break repair gene in human and mouse. Genomics 1996, 36:305-315.
72. McShea A., Harris P.L., Webster K.R., Wahl A.F., Smith M.A. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am. J. Pathol. 1997, 150:1933-1939.
73. McShea A., Lee H., Peterson R.B. Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim. Biophys. Acta 2007, 4:467-472.
74. Migliore L., Testa A., Scarpato R., Pavese N., Petrozzi L., Bonuccelli U. Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum. Genet. 1997, 101:299-305.
75. Migliore L., Boni G., Bernardini R., Trippi F., Colognato R., Fontana I., Coppedè F., Sbrana I. Susceptibility to chromosome malsegregation in lymphocytes of women who had a Down syndrome child in young age. Neurobiol. Aging 2006, 27:710-716.
76. Migliore L., Migheli F., Coppedè F. Susceptibility to aneuploidy in young mothers of Down syndrome children. ScientificWorldJournal 2009, 9:1052-1060.
77. Migliore L., Coppedè F., Fenech M., Thomas P. Association of micronucleus frequency with neurodegenerative diseases. Mutagenesis 2011, 26:85-92.
78. Moorhead P.S., Heyman A. Chromosome studies of patients with Alzheimer disease. Am. J. Med. Genet. 1983, 14:545-556.
79. Mora-Santos M., Castilla C., Herrero-Ruiz J., Giráldez S., Limón-Mortés M.C., Sáez C., Japón M.Á., Tortolero M., Romero F. A single mutation in Securin induces chromosomal instability and enhances cell invasion. Eur. J. Cancer 2013, 49:500-510.
80. Moh C., Kubiak J.Z., Bajic V.P., Zhu X., Smith M.A., Lee H.G. Cell cycle deregulation in the neurons of Alzheimer's disease. Results Probl. Cell Differ. 2011, 53:565-576.
81. Mosch B., Morawski M., Mittag A., Lenz D., Tarnok A., Arendt T. Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J. Neurosci. 2007, 27:6859-6867.
82. Nagy Z. Cell cycle regulatory failure in neurons: causes and consequences. Neurobiol. Aging 2000, 21:761-769.
83. Nasmyth K. How do so few control so many?. Cell 2005, 120:739-746.
84. Nasmyth K., Haering C.H. Cohesin: its roles and mechanisms. Annu. Rev. Genet. 2009, 43:525-558.
85. Nasmyth K., Peters J.M., Uhlmann F. Splitting the chromosome: cutting the ties that bind sister chromatides. Science 2000, 288:1379-1385.
86. Ogawa O., Zhu X., Lee H.G., Raina A., Obrenovich M.E., Bowser R., Ghanbari H.A., Castellani R.J., Perry G., Smith M.A. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?. Acta Neuropathol. 2003, 105:524-528.
87. Oromendia A.B., Amon A. Aneuploidy: implications for protein homeostasis and disease. Dis. Model. Mech. 2014, 7:15-20.
88. Orstavik K.H. Skewed X inactivation in healthy individuals and in different diseases. Acta Paediatr. Suppl. 2006, 95:24-29.
89. Orstavik K.H. X chromosome inactivation in clinical practice. Hum. Genet. 2009, 126:363-373.
90. Oyama F., Cairns N.J., Shimada H., Oyama R., Titani K., Ihara Y. Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination. J. Neurochem. 1994, 62:1062-1066.
91. Patterson D., Costa A.C. Down syndrome and genetics - a case of linked histories. Nat. Rev. Genet. 2005, 6:137-147.
92. Perera D., Tilston V., Hopwood J.A., Barchi M., Boot-Handford R.P., Taylor S.S. Bub1 maintains centromeric cohesion by activation of the spindle checkpoint. Dev. Cell 2007, 13:566-579.
93. Petersen M.B., Karadima G., Samaritaki M., Avramopoulos D., Vassilopoulos D., Mikkelsen M. Association between presenilin-1 polymorphism and maternal meiosis II errors in Down syndrome. Am. J. Med. Genet. 2000, 93:366-372.
94. Petronis A. Alzheimer's disease and Down syndrome: from meiosis to dementia. Exp. Neurol. 1999, 158:403-413.
95. Petrozzi L., Lucetti C., Scarpato R., Gambaccini G., Trippi F., Bernardini S., Del Dotto P., Migliore L., Bonuccelli U. Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients. Neurol. Sci. 2002, 23(Suppl. 2):S97L 8.
96. Plenge R.M., Stevenson R.A., Lubs H.A., Schwartz C.E., Willard H.F. Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders. Am. J. Hum. Genet. 2001, 71:168-173.
97. Pomp O., Dreesen O., Colman A. The X factor in cellular reprogramming and proliferation. Cell Cycle 2011, 10:3992-3993.
98. Pomp O., Dreesen O., Leong D.F., Meller-Pomp O., Tan T.T., Zhou F., Colman A. Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. Cell Stem Cell 2011, 9:156-165.
99. Potter H. Review and hypothesis: Alzheimer disease and Down syndrome-chromosome 21 nondisjunction may underlie both disorders. Am. J. Hum. Genet. 1991, 48:1192-1200.
100. Potter H. Down's syndrome and Alzheimer's disease: two sides of the same coin. Future Neurol. 2008, 3:29-37.
101. Provost P. Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases. Aging (Albany, NY) 2010, 2:166-169.
102. Puram S.V., Kim A.H., Bonni A. An old dog learns new tricks: a novel function for Cdc20-APC in dendrite morphogenesis in neurons. Cell Cycle 2010, 9:482-485.
103. Sathasivam S., Ince P.G., Shaw P.J. Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol. Appl. Neurobiol. 2001, 27:257-274.
104. Schupf N., Kapell D., Lee J.H., Ottman R., Mayeux R. Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet 1994, 344:353-356.
105. Schupf N., Patel B., Silverman W., Zigman W.B., Zhong N., Tycko B., Mehta P.D., Mayeux R. Elevated plasma amyloid β-peptide 1-42 and onset of dementia in adults with Down syndrome. Neurosci. Lett. 2001, 301:199-203.
106. Silva-Grecco R.L1, Navarro G.C., Cruz R.M., Balarin M.A. Micronucleated lymphocytes in parents of Down syndrome children. Braz. J. Med. Biol. Res. 2012 Jul, 45(7):573-577.
107. Smith M.A. Alzheimer's disease. Int. Rev. Neurobiol. 1998, 42:1-54.
108. Smith K.G., Lowther E., Maher T., Hourihan T., Wilkinson T., Wolstenholme J. The predictive value of findings of the common aneuploidies, trisomies 13, 18 and 21, and numerical sex chromosome abnormalities at CVS: experience from the ACC U.K. collaborative study. Prenat. Diagn. 1999, 19:817-826.
109. Splinter E., de Wit E., Nora E.P., Klous P., van de Werken H.J.G., Zhu Y., Kaaij L.J.T., van Ijcken W., Gribnau J., Heard E., de Laat W. The inactive X chromosome adopts a unique three-dimensional conformation that is dependent on Xist RNA. Genes Dev. 2011, 25:1371-1383.
110. Spremo-Potparevic B., Zivkovic L., Djelic N., Bajic V. Analysis of premature centromere division (PCD) of the X chromosome in Alzheimer patients through the cell cycle. Exp. Gerontol. 2004, 39:849-854.
111. Spremo-Potparevic B., Zivkovic L., Djelic N., Plecas-Solarovic B., Smith M.A., Bajic V. Premature centromere division of the X chromosome in neurons in Alzheimer's disease. J. Neurochem. 2008, 106:2218-2223.
112. Staessen C., Maes A.M., Kirsch-Volders M., Susanne C. Is there a predisposition for meiotic nondisjunction that may be detected by mitotic hyperploidy?. Clin. Genet. 1983, 24:184-190.
113. Stanton L.R., Coetzee R.H. Down's syndrome and dementia. Adv. Psychol. Treat. 2004, 10:50-58.
114. Stegmüller J., Bonni A. Moving past proliferation: new roles for Cdh1-APC in postmitotic neurons. Trends Neurosci. 2005, 28:596-601.
115. Strittmatter W.J., Weisgraber K.H., Goedert M., Saunders A.M., Huang D., Corder E.H., Dong L.M., Jakes R., Alberts M.J., Gilbert J.R., Roses A.D. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain as a function of apolipoprotein E genotype. Exp. Neurol. 1994, 125:163-171.
116. Teng F.Y., Tang B.L. APC/C regulation of axonal growth and synaptic functions in postmitotic neurons: the Liprin-alpha connection. Cell. Mol. Life Sci. 2005, 62:1571-1578.
117. Thomas P., Hecker J., Faunt J., Fenech M. Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease. Mutagenesis 2007, 22:371-379.
118. Thomas P., Fenech M. Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease. Mutagenesis 2008, 23:57-65.
119. Thompson T., Danilenko M., Vassilev L., Studzinski G.P. Tumor suppressor p53 status does not determine the differentiation-associated G1 cell cycle arrest induced in leukemia cells by 1,25-dihydroxyvitamin D3 and antioxidants. Cancer Biol. Ther. 2010, 10(4):344-350.
120. Trippi F., Botto N., Scarpato R., Petrozzi L., Bonuccelli U., Latorraca S., Sorbi S., Migliore L. Spontaneous and induced chromosome damage in somatic cells of sporadic and familial Alzheimer's disease patients. Mutagenesis 2001, 16:323-327.
121. Viña J., Lloret A.J. Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-beta peptide. Alzheimer's Dis. Suppl. 2010, 2:S527-S533.
122. Vincent I., Rosado M., Davies P. Mitotic mechanisms in Alzheimer's disease?. J. Cell Biol. 1996, 132:413-425.
123. Vincent I., Jicha G., Rosado M., Dickson D.W. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 1997, 17:3588-3598.
124. Wang Z., Yu R., Melmed S. Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol. Endocrinol. 2001, 15:1870-1879.
125. Wang W., Bu B., Xie M., Zhang M., Yu Z., Tao D. Neural cell cycle dysregulation and central nervous system diseases. Prog. Neurobiol. 2009, 89(1):1-17.
126. Wendt K.S., Yoshida K., Itoh T., Bando M., Koch B., Schirghuber E., Tsutsumi S., Nagae G., Ishihara K., Mishiro T., Yahata K., Imamoto F., Aburatani H., Nakao M., Imamoto N., Maeshima K., Shirahige K., Peters J.M. Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 2008, 451:796-801.
127. Westra J.W., Rivera R.R., Bushman D.M., Yung Y.C., Peterson S.E., Barral S., Chun J. Neuronal DNA content variation (DCV) with regional and individual differences in the human brain. J. Comp. Neurol. 2010, 518:3981-4000.
128. Wirth K.G., Ricci R., Giménez-Abián J.F., Taghybeeglu S., Kudo N.R., Jochum W., Vasseur-Cognet M., Nasmyth K. Loss of the anaphase-promoting complex in quiescent cells causes unscheduled hepatocyte proliferation. Genes Dev. 2004, 18:88-98.
129. Yang Y., Geldmacher D.S., Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 2001, 21:2661-2668.
130. Yang Y., Mufson E.J., Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J. Neurosci. 2003, 23:2557-2563.
131. Yang Y., Varvel N.H., Lamb B.T., Herrup K. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J. Neurosci. 2006, 26:775-784.
132. Yang Y., Kim A.H., Bonni A. The dynamic ubiquitin ligase duo: Cdh1-APC and Cdc20-APC regulate neuronal morphogenesis and connectivity. Curr. Opin. Neurobiol. 2010, 20:92-99.
133. Yang F., Trolle Lagerros Y., Bellocco R., Adami H.O., Fang F., Pedersen N.L., Wirdefeldt K. Physical activity and risk of Parkinson's disease in the Swedish National March Cohort. Brain 2015, 138:269-275.
134. Yasuda T., Nakata Y., Mochizuki H. a-Syn and neuronal cell death. Mol. Neurobiol. 2013, 47:466-483.
135. Yurov Y.B., Iourov I.Y., Vorsanova S.G., Liehr T., Kolotii A.D., Kutsev S.I., Pellestor F., Beresheva A.K., Demidova I.A., Kravets V.S., Monakhov V.V., Soloviev I.V. Aneuploidy and confined chromosomal mosaicism in the developing human brain. PLoS ONE 2007, 2:e558.
136. Yurov Y.B., Vorsanova S.G., Iourov I.Y. GIN'n'CIN hypothesis of brain aging: deciphering the role of somatic genetic instabilities and neural aneuploidy during ontogeny. Mol. Cytogenet. 2009, 25:2-23.
137. Yurov Y.B., Vorsanova S.G., Iourov I.Y. Ontogenetic variation of the human genome. Curr. Genomics 2010, 11:420-425.
138. Yurov Y.B., Vorsanova S.G., Iourov I.Y. The DNA replication stress hypothesis of Alzheimer's disease. ScientificWorldJournal 2012, 11:2602-2612.
139. Yurov Y.B., Vorsanova S.G., Liehr T., Kolotii A.D., Iourov I.Y. X chromosome aneuploidy in the Alzheimer's disease brain. Mol. Cytogenet. 2014, 7:20.
140. Zekanowski C., Wojda U. Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease. Acta Neurobiol. Exp. (Wars) 2009, 69:232-253.
141. Zhu X., Raina A.K., Boux H., Simmons Z.L., Takeda A., Smith M.A. Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int. J. Dev. Neurosci. 2000, 18:433-437.
142. Zhu X., Lee H.G., Perry G., Smith M.A. Alzheimer disease, the two-hit hypothesis: an update. Biochim. Biophys. Acta 2007, 72(4):494-502.
143. Zivković L., Spremo-Potparević B., Djelić N., Bajić V. Analysis of premature centromere division (PCD) of the chromosome 18 in peripheral blood lymphocytes in Alzheimer disease patients. Mech. Ageing Dev. 2006, 127:892-896.
144. Zivković L., Spremo-Potparević B., Plecas-Solarović B., Djelić N., Ocić G., Smiljković P., Siedlak S.L., Smith M.A., Bajić V. Premature centromere division of metaphase chromosomes in peripheral blood lymphocytes of Alzheimer's disease patients: relation to gender and age. J. Gerontol. A: Biol. Sci. Med. Sci. 2010, 65:1269-1274.